The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

After losing 30 pounds, Ed Sheeran is opening up about what motivated his health transformation. The singer appears in the January 2026 issue of Men's Health UK and shares what inspired him to embark ...

Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...

August 2025 was a busy time for the physical fitness displays of American politicians. U.S. Department of Health and Human Services shared a weight-lifting video of Secretary Robert F. Kennedy Jr. and ...

Retatrutide works by mimicking three hunger-regulating hormones. A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

You arrive at the gym and find yourself at a familiar crossroads: Turn this way for the weight room, or that way for the cardio deck. You planned to do both—but which should you do first? Does it even ...

Amy Schumer is showing off her dramatic weight loss in a tiny yellow minidress. The comedian, 44, posed on a flight of carpeted stairs in Instagram pics she posted Saturday. Wearing a show-stopping ...

Lizzo believes we, as a society, must “undo the effects of the Ozempic boom” because plus-sized women are being “erased.” The musician, 37, took to Substack on Sunday to share an essay titled, “Why is ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...